FDA approves weight-loss drug Zepbound for obstructive sleep apnea
By Meg Tirrell, CNN (CNN) — The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as GLP-1 receptor agonists that also includes Ozempic, was cleared to treat moderate to severe forms of the sleep condition in
Continue Reading